Skip to main content
Log in

A case of encapsulating peritoneal sclerosis presented shortly after renal transplantation

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD), characterized by extensive intraperitoneal fibrosis and encasement of bowel loops. It typically associates with long-term PD and progressive loss of ultrafiltration. The management of EPS has evolved substantially from the original report of this entity and now includes immunosuppressive agents, antifibrotic agents, nutritional support, and surgical intervention. Although the exact cause of this condition remains obscure and despite the possible positive effect of immunosuppression on EPS, it has been described in the post-transplant setting upon the discontinuation of PD. We report such a case of a former PD patient who presented with EPS a month after renal transplantation. This article will highlight the current views regarding the management of post-transplant EPS and introduce the problem of long-term PD patients on the deceased-donor transplant waiting list.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, Geis WP, Hano JE. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med. 1980;140:1201–3.

    Article  CAS  PubMed  Google Scholar 

  2. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20(Suppl 4):S43–55.

    PubMed  Google Scholar 

  3. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int. 2005;25(Suppl 4):S39–47.

    PubMed  Google Scholar 

  4. Kawanishi H. Surgical treatment for encapsulating peritoneal sclerosis. Adv Perit Dial. 2002;18:139–43.

    PubMed  Google Scholar 

  5. Habib SM, Betjes MG, Fieren MW, Boeschoten EW, Abrahams AC, Boer WH, Struijk DG, Ruger W, Krikke C, Westerhuis R, de Sévaux RG, van der Sande FM, Gaasbeek A, Korte MR; Eps Registry. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med. 2011;69:500–7.

    CAS  PubMed  Google Scholar 

  6. Tomino Y. Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol. 2012;16:109–14.

    Article  PubMed  Google Scholar 

  7. Hawley CM, Wall DR, Johnson DW, Campbell SB, Griffin AD, Rigby RJ, Petrie JJ. Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1995;26:658–61.

    Article  CAS  PubMed  Google Scholar 

  8. Garosi G, Oreopoulos DG. No need for an “expiry date” in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis. Int Urol Nephrol. 2009;41:903–7.

    Article  PubMed  Google Scholar 

  9. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int. 2007;27:619–24.

    PubMed  Google Scholar 

  10. Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical aspects of sclerosing encapsulating peritonitis. Arch Surg. 1990;125:1626–8.

    Article  CAS  PubMed  Google Scholar 

  11. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, Tranaeus A. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int. 2005;25(Suppl 4):S83–95.

    PubMed  Google Scholar 

  12. Yamamoto T, Nagasue K, Okuno S, Yamakawa T. The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit Dial Int. 2010;30:343–52.

    Article  PubMed  Google Scholar 

  13. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol. 1999;12:395–7.

    CAS  PubMed  Google Scholar 

  14. Mohamed AO, Kamar N, Nogier MB, Esposito L, Duffas JP, Rostaing L. Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection. Exp Clin Transplant. 2009;7:164–7.

    PubMed  Google Scholar 

  15. Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MG; investigators of the Dutch Multicentre EPS Study. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant. 2011;26:691–7.

    Article  CAS  PubMed  Google Scholar 

  16. Toyohara T, Ubara Y, Higa Y, Suwabe T, Hoshino J, Sumida K, Hiramatsu R, Nagasawa M, Hasegawa E, Yamanouchi M, Hayami N, Marui Y, Sawa N, Nakamura M, Tomikawa S, Takaichi K. Prognosis of patients on continuous ambulatory peritoneal dialysis (CAPD) for over 10 years. Intern Med. 2011;50:2519–23.

    Article  PubMed  Google Scholar 

  17. Dejagere T, Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y. Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient. Am J Kidney Dis. 2005;45:e33–7.

    Article  PubMed  Google Scholar 

  18. Lafrance JP, Létourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, Pichette V. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis. 2008;51:e7–10.

    Article  PubMed  Google Scholar 

  19. Adamidis KN, Zachariou CA, Kopaka ME, Charitaki EE, Drakopoulos V, Kara P, Drakopoulos S, Apostolou T. Sclerosing peritonitis presenting 2 years after renal transplantation in a former CAPD patient. Ren Fail. 2011;33:246–8.

    Article  PubMed  Google Scholar 

  20. Debska-Slizien A, Konopa J, Januszko-Giergielewicz B, Wolyniec Z, Wolyniec W, Chamienia A, Rutkowski B. Posttransplant encapsulating peritoneal sclerosis: presentation of cases and review of the literature. J Nephrol. 2012. doi:10.5301/jn.5000230.

  21. Fontana I, Bertocchi M, Santori G, Ferrari G, Barabani C, Valente U. Encapsulating peritoneal sclerosis after kidney transplantation: a single-center experience from 1982 to 2010. Transplant Proc. 2012;44:1918–21.

    Article  CAS  PubMed  Google Scholar 

  22. Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int. 2002;62:2257–63.

    Article  CAS  PubMed  Google Scholar 

  23. Summers AM, Abrahams AC, Alscher MD, Betjes M, Boeschoten EW, Braun N, Brenchley PE, Davies S, Dunn L, Engelsman L, Fieren M, Garosi G, Goffin E, Heuveling L, Korte M, Lindholm B, Rutherford P, Struijk D, Verduijn M, Verger C, Westerhuis R. A collaborative approach to understanding EPS: the European perspective. Perit Dial Int. 2011;31:245–8.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All the authors have declared no competing interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Georgios Spanos.

About this article

Cite this article

Spanos, G., Harissis, H.V., Dounousi, E. et al. A case of encapsulating peritoneal sclerosis presented shortly after renal transplantation. CEN Case Rep 3, 40–43 (2014). https://doi.org/10.1007/s13730-013-0079-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-013-0079-9

Keywords

Navigation